As explained in Fig 10, we suggest that the anti-fibrotic effect of piceatannol is related to the inhibition of the TGF-β1/Smad-independent pathway but not to that of the TGF-β1/Smad-dependent pathway in the UUO-induced fibrosis model. This evidence concerns the gene TGFB1 and fibrosis.